Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis

PURPOSE: The systemic immune-inflammation index (SII) has been considered a novel prognostic biomarker in several types of lymphoma. Our aims were to determine the best statistical relationship between pretreatment SII and survival and to combination of SII and the Memorial Sloan Kettering Cancer Ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shengjie, Xia, Zuguang, Cao, Jiazhen, Zhang, Jinsen, Chen, Bobin, Chen, Tong, Zhang, Xin, Zhu, Wei, Li, Danhui, Hua, Wei, Mao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681794/
https://www.ncbi.nlm.nih.gov/pubmed/36439151
http://dx.doi.org/10.3389/fimmu.2022.1039862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681794/
https://www.ncbi.nlm.nih.gov/pubmed/36439151
http://dx.doi.org/10.3389/fimmu.2022.1039862

Ejemplares similares